SEC Form 4 · accession 0001104659-16-124074
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gino Santini
Director
Period of report
May 26, 2016
Accepted (ET)
May 27, 2016 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.62 | May 26, 2016 | A | 10,000 | A | — | Jun 25, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option vests in four (4) equal quarterly installments following May 26, 2016.